Old silver Venture Capital
Old Silver Venture Capital

ABOUT

Old Silver VC is an evergreen family-associated fund that makes early stage investments in Biotech, Digital Health, AI, and Material Sciences. We believe that the world’s greatest problems can be solved with innovative science and technology solutions. We seek and support early-stage founders with a vision that can scale from science fiction to new reality.
Old Silver Venture Capital Investors

Artificial Intelligence

Artificial Intelligence Investments

Material Sciences

Material Sciences Investments
Biotechnology Investments

Biotechnology

Digital Health Investments

Digital Health

Old Silver Venture Capital Investors
Biotechnology

Biotechnology

Artificial Intelligence

Digital Technology
Artificial Intelligence

Digital Health

Material Sciences

Networks and Computing

TEAM

KNOWLEDGE, EXPERIENCE,
KINDNESS

Michael Langer
Founding Partner

Michael is the Founding Partner at Old Silver VC, the Head of Search and Evaluation at Pear Therapeutics and a World Economic Forum Global Shaper.

LinkedIn
Susan Langer
Venture Partner

Vice President of Business Development at a Cambridge-based cell state start up in stealth mode.

LinkedIn
Andrew Emmons, MBA
Managing Director

Focuses on early-stage investments in the technology, SaaS, and healthcare industries.

LinkedIn
Eric Shen
Managing Director

Well versed in corporate development and strategic & operational excellence focusing on biotechnology and healthcare.

LinkedIn

FELLOWS

Aditya Shah

Passionate about companies building high impact solutions at the intersection of health and technology. Currently supporting Growth at Oscar Health.

LinkedIn
Cassandra Villicana

PhD Candidate at Stanford University researching biomaterial-based immunomodulation strategies for tissue engineering

LinkedIn
Cristiano Peron, MD

Physician-scientist currently completing his PhD at the University of Oxford. He focuses on translational research in Oncology.

LinkedIn
David Paik, PhD

Instructor at Stanford Cardiovascular Institute and Stanford University School of Medicine. Passionate about investing in companies that generate novel therapeutics and innovative tools to treat patients.

LinkedIn
Kun Lyu, PhD

Postdoctoral researcher at Stanford University working in the field of health data science, wearable technology, and AI in precision medicine. Passionate about innovations in health monitoring and the application of AI in biotech development and medicine.

LinkedIn
Tiffany Ma, MTM

PhD candidate at the University of Oxford researching strategies to target therapy-resistant tumours in solid cancers. Passionate about biotech innovations that expedite the bench top to bedside process.

LinkedIn

ADVISORS

Adam Śmiechowski

Senior software engineer at Microsoft whose expertise spans multiple verticals of the software engineering domains and a number of programming languages including C, C++, C# and Python.

LinkedIn
Alicia Chong Rodriguez, MS, MSc

Femtech Catalyst, Founder & CEO at Bloomer Tech: Tailoring cardiovascular care for women via an augmented garment platform and novel digital biomarkers.

LinkedIn
Medha Sharma

M.D. candidate at the Perelman School of Medicine passionate about innovation in biotech, digital health, and health equity.

LinkedIn
David Mou, MBA, MD

Chief Medical Officer at Cerebral & Co-founder / former CMO of Valera Health, a venture-backed digital healthcare company.

LinkedIn
Emilia Javorsky, MD, MPH

Physician-Scientist and former Harvard Medical School researcher focused on the development and translation of medical technologies.

LinkedIn
Everett Crosland, MS, JD

Life sciences executive, with a proven track record commercializing and scaling complex drugs, drug-device combos, and digital therapeutics.

LinkedIn
Giovanni Thermot

Co-founder of ThoughtMetric Inc- a next-generation analytics platform designed to help Mid-Market and SMB eCommerce stores better understand their customers.

LinkedIn
Jordan Haviland, MBA

CEO of Brattle Point, LLC, where he focuses on acquiring growing technology and service businesses in scientific and industrial markets.

LinkedIn
Livio Valenti, MPP

Sustainability entrepreneur and co-founder of Vaxess Technologies, a biotechnology company reimagining vaccine delivery.

LinkedIn
Liz Kwo, MD, MBA, MPH

Deputy Chief Clinical Officer at Anthem & Co-Founder / former CEO of InfiniteMD.

LinkedIn
Louis Kang, PhD

Managing Director at AccelR8, Co-Founder at MitoLab, Venture Partner at Korea Technology Bank (KTB) VC

LinkedIn
Matthew Lanchantin

Fund advisor specializing in life sciences and biotechnology investments. He brings over 7 years of industry experience as both a bioengineer and business development professional.

LinkedIn
Millie Liu

Founding Partner at First Star Ventures, an early-stage venture fund focuses on cutting edge data technologies.

LinkedIn
Pavan Choksi

Partner at Arkitekt Ventures

LinkedIn
Rebecca Maynard, LLM, JD

Compliance & Privacy Specialist at Boston Children's Hospital

LinkedIn
Rose Wang

Head of CX at NLP startup Forethought.ai, winner of TechCrunch Disrupt and funded by NEA, Village Global, K9 Ventures, etc.

LinkedIn
Ryan Coles, MS, PHD

Assistant Professor of Entrepreneurial Management at UConn's School of Business, and the Chief Science Officer at Human Wealth.

LinkedIn
Sean Cheng, MP, PHD

Early stage investor in health tech companies and is currently excited about digital therapeutics, remote patient care, novel devices, and disruptive enablers.

LinkedIn
Sophie Bai, MBA

Founder and CEO of a biotech company using novel transdermal drug delivery technologies to get large molecules into the skin.

LinkedIn
Zack Gow, ME, MS

Data scientist, machine learning engineer, and entrepreneur.

LinkedIn
Freddie Martignetti, MBA
Senior Advisor

Investor at Highland Capital Partners, a global leader in early stage consumer and enterprise technology investments.

LinkedIn
Robert Langer, Sc. D
Senior Advisor

Dr. Langer is one of 10 Institute professors at MIT (MITs highest honor). He is an expert in the fields of tissue engineering and drug delivery and has founded over 40 startup companies. He is the most cited engineer in history. 

LinkedIn
OLD SILVER
Improving Companies Investments
NEW SILVER

PORTFOLIO

ACQ
IPO
Bloomer Tech
ACQ
IPO
Phoenix Tailings
ACQ
IPO
Curie Co
ACQ
IPO
ACQ
IPO
Beta Hatch
ACQ
IPO

Prior Investments or Early Shareholder Positions

ACQ
IPO
Alto Pharmacy
ACQ
IPO
Modulate AI
ACQ
IPO
Revolutionary Clinics
ACQ
IPO
Luminopia
ACQ
IPO
Plex Research
ACQ
IPO
Modern Meadow
ACQ
IPO
ATAI Life Sciences
ACQ
IPO
Mori
ACQ
IPO
Moderna Biotechnology
ACQ
IPO
Frequency Therapeutics
ACQ
IPO
Alnylam Biopharmaceuticals
ACQ
IPO
Momenta Pharmaceuticals
ACQ
IPO
Kala Biopharmaceuticals Eye
ACQ
IPO
Lyndra Therapeutics
ACQ
IPO
Sigilon
ACQ
IPO
Seer Biology
ACQ
IPO
SQZ Biotech
ACQ
IPO
Living Proof Haircare
ACQ
IPO
Vida Ventures
ACQ
IPO
Boston Seed Capital
Email

CONTACT

If you're building something people say isn’t going to work, please message us, we would love to talk.

Andrew@oldsilvervc.com